208 rue des Apothicaires,
34298 Montpellier Cedex 05.
Following a PhD in Biochemistry and Molecular Biology and a postdoctoral stay in the laboratory of Molecular Pharmacology (Dr Y. Pommier) at the National Cancer Institute, Dr Pourquier acquired a solid experience in the field of DNA topoisomerases and their inhibitors used in cancer chemotherapy.
In 2001 he obtained a senior investigator position at INSERM.
He is developing basic research programs in the field of drug resistance to topoisomerase inhibitors and has recently developed translational research programs to identify alternative therapies for the treatment of castration-resistant prostate cancers and new markers of sensitivity to anticancer drugs that are used or developed in that indication.
Dr Philippe Pourquier obtained a doctorate (Ph.D.) in Biochemistry and Molecular Biology from the University of Bordeaux, France.
Dr Pourquier also holds a Pharmacy Doctorate from the same University.
Dr Pourquier is currently a Research Director at the french National Institute of Health and Medical Research (INSERM) in the research unit U1194 in Montpellier, France.
Dr Pourquier acquired a solid experience in the field of drug resistance to anticancer agents, in particular DNA topoisomerases’ inhibitors and has published more than 60 papers in this field.
He is developing basic and translational research programs to identify alternative therapies for the treatment of castration-resistant prostate cancers.